Literature DB >> 4606856

NOSIE--30: history and current status of its use in pharmacopsychiatric research.

G Honigfeld.   

Abstract

Mesh：

Year:  1974        PMID： 4606856     DOI： 10.1159/000395079

Source DB:  PubMed          Journal:  Mod Probl Pharmacopsychiatry        ISSN： 0077-0094


× No keyword cloud information.
  11 in total

1.  Italian validation of MOAS and NOSIE: a useful package for psychiatric assessment and monitoring of aggressive behaviours.

Authors:  Francesco Margari; Rosanna Matarazzo; Massimo Casacchia; Rita Roncone; Massimiliano Dieci; Simona Safran; Giovanni Fiori; Lucia Simoni
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

2.  Effects of supidimide in schizophrenic inpatients undergoing neuroleptic maintenance therapy with haloperidol.

Authors:  V Rapisarda; E Aguglia; A Poma
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  The clinical assessment of depression.

Authors:  M Lader
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

4.  Action of d-propranolol in manic psychoses.

Authors:  H J Möller; D von Zerssen; H M Emrich; W Kissling; C Cording; H J Schietsch; E Riedel
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979-12

5.  [The effect of the beta-adrenergic blocking agent propranolol in mania (author's transl)].

Authors:  W Rackensperger; W Fritsch; D Schwarz; K H Stutte; D Zerssen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-10-28

6.  Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT).

Authors:  A Wettstein; R Spiegel
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.

Authors:  B Saletu; E Paulus; L Linzmayer; P Anderer; H V Semlitsch; J Grünberger; L Wicke; A Neuhold; I Podreka
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

8.  Memantine for dementia.

Authors:  Rupert McShane; Maggie J Westby; Emmert Roberts; Neda Minakaran; Lon Schneider; Lucy E Farrimond; Nicola Maayan; Jennifer Ware; Jean Debarros
Journal:  Cochrane Database Syst Rev       Date:  2019-03-20

9.  EXPLAIN Fragile-X: an explorative, longitudinal study on the characterization, treatment pathways, and patient-related outcomes of Fragile X Syndrome.

Authors:  Frank Haessler; Franziska Gaese; Michael Colla; Michael Huss; Christoph Kretschmar; Marc Brinkman; Heike Schieb; Helmut Peters; Samuel Elstner; David Pittrow
Journal:  BMC Psychiatry       Date:  2013-12-19       Impact factor: 3.630

Review 10.  Increasing antipsychotic dose for non response in schizophrenia.

Authors:  Myrto T Samara; Elisabeth Klupp; Bartosz Helfer; Philipp H Rothe; Johannes Schneider-Thoma; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2018-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.